Search
forResearch 10 of 1000+
- Phenol in dermatology: updated evidence on efficacy and safety
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- Pressure-induced alopecia following cardiac surgery
- Topical minoxidil: cardiac effects in bald man.
- Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Testosterone therapy in women: Myths and misconceptions
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
Community 3 of 12
- I experienced severe cardiac and renal side effects with only 1.25 mg of minoxidil
- The Biggest Concern That I Have For Oral Minoxidil: Cardiac Hypertrophy
- The dose dependent nature of the cardiac effects RU58841
Learn
— no results
Try a deeper search in learn →